FOLFOX Chemotherapy Combined With Fruquintinib and Serplulimab as First-Line Conversion Therapy for Initially Unresectable pMMR/MSS Colorectal Cancer
Fudan University
Fudan University
Ottawa Hospital Research Institute
University of Chicago
Centre Francois Baclesse
Fudan University
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
M.D. Anderson Cancer Center
Spanish Breast Cancer Research Group
Spanish Breast Cancer Research Group
Ataturk University
Centre hospitalier de l'Université de Montréal (CHUM)
Universitätsklinikum Hamburg-Eppendorf
Qianfoshan Hospital
Hospital Universitari de Bellvitge
American University of Beirut Medical Center
The University of Texas Medical Branch, Galveston
Korea University
Ain Shams Maternity Hospital
Centre Francois Baclesse
Bispebjerg Hospital
Fudan University
Fudan University
University of Florida
Hospices Civils de Lyon
Dermatologic Cooperative Oncology Group